Cargando…

Design and Development of Autotaxin Inhibitors

Autotaxin (ATX) is the only enzyme of the ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP2) family with lysophospholipase D (lysoPLD) activity, which is mainly responsible for the hydrolysis of extracellular lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA). LPA can induce vario...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Yi, Li, Yan, Xu, Xu-Dong, Tian, Yu, Shang, Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622848/ https://www.ncbi.nlm.nih.gov/pubmed/34832985 http://dx.doi.org/10.3390/ph14111203

Ejemplares similares

Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis
por: Banerjee, Souvik, et al.
Publicado: (2022)

Pharmacophoric Site Identification and Inhibitor Design for Autotaxin
por: Lee, Myeong Hwi, et al.
Publicado: (2019)

Chemical Evolution of Autotaxin Inhibitors
por: Albers, Harald M. H. G., et al.
Publicado: (2012)

Benzoxaboroles—Novel Autotaxin Inhibitors
por: Kraljić, Kristina, et al.
Publicado: (2019)

Structure-Based Design of Novel Boronic Acid-Based Inhibitors of Autotaxin
por: Albers, Harald M. H. G., et al.
Publicado: (2011)

Autotaxin Implication in Cancer Metastasis and Autoimunne Disorders: Functional Implication of Binding Autotaxin to the Cell Surface
por: Peyruchaud, Olivier, et al.
Publicado: (2019)

The Expression Regulation and Biological Function of Autotaxin
por: Zhang, Xiaotian, et al.
Publicado: (2021)

Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
por: Valdés-Rives, Silvia Anahi, et al.
Publicado: (2017)

Another name for autotaxin
por: Dove, Alan W.
Publicado: (2002)

Structure-Based Design of a Novel Class of Autotaxin Inhibitors Based on Endogenous Allosteric Modulators
por: Clark, Jennifer M., et al.
Publicado: (2022)

Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
por: She, Sha, et al.
Publicado: (2022)

Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease
por: Ramesh, Sindhu, et al.
Publicado: (2018)

Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors
por: Magkrioti, Christiana, et al.
Publicado: (2020)

Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives
por: Zulfikar, Sabrina, et al.
Publicado: (2020)

The Effect of Anti-Autotaxin Aptamers on the Development of Proliferative Vitreoretinopathy
por: Hanazaki, Hirotsugu, et al.
Publicado: (2023)

Autotaxin in Pathophysiology and Pulmonary Fibrosis
por: Ninou, Ioanna, et al.
Publicado: (2018)

Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors
por: Deken, M.A., et al.
Publicado: (2023)

Synthesis, Characterization, and in vivo Evaluation of a Novel Potent Autotaxin-Inhibitor
por: Hunziker, Daniel, et al.
Publicado: (2022)

The Structural Binding Mode of the Four Autotaxin Inhibitor Types that Differentially Affect Catalytic and Non-Catalytic Functions
por: Salgado-Polo, Fernando, et al.
Publicado: (2019)

MicroRNA Regulation of the Autotaxin-Lysophosphatidic Acid Signaling Axis
por: Murph, Mandi M.
Publicado: (2019)

Autotaxin and Breast Cancer: Towards Overcoming Treatment Barriers and Sequelae
por: Benesch, Matthew G. K., et al.
Publicado: (2020)

Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications
por: Drosouni, Andrianna, et al.
Publicado: (2022)

The Role of Autotaxin and LPA Signaling in Embryonic Development, Pathophysiology and Cancer
por: Magkrioti, Christiana, et al.
Publicado: (2023)

Exocrine Pancreatic Carcinogenesis and Autotaxin Expression
por: Kadekar, Sandeep, et al.
Publicado: (2012)

Usefulness of autotaxin for the complications of liver cirrhosis
por: Shao, Xue, et al.
Publicado: (2020)

Role of autotaxin in systemic lupus erythematosus
por: Tsuchida, Yumi, et al.
Publicado: (2023)

Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
por: Centonze, Matteo, et al.
Publicado: (2023)

Autotaxin Inhibition with IOA-289 Decreases Breast Tumor Growth in Mice Whereas Knockout of Autotaxin in Adipocytes Does Not
por: Tang, Xiaoyun, et al.
Publicado: (2023)

Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease
por: Jose, Anu, et al.
Publicado: (2021)

Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer
por: Yun, C. Chris
Publicado: (2019)

Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders
por: Alioli, Candide, et al.
Publicado: (2022)

A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis
por: Booijink, Richell, et al.
Publicado: (2022)

Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
por: Centonze, Matteo, et al.
Publicado: (2023)

Lysophospholipids in the limelight: autotaxin takes center stage
por: Moolenaar, Wouter H.
Publicado: (2002)

Novel point mutations attenuate autotaxin activity
por: Koh, Eunjin, et al.
Publicado: (2009)

Autotaxin and Endotoxin-Induced Acute Lung Injury
por: Mouratis, Marios-Angelos, et al.
Publicado: (2015)

Hepatic autotaxin overexpression in infants with biliary atresia
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2018)

Autotaxin: Its Role in Biology of Melanoma Cells and as a Pharmacological Target
por: Jankowski, Maciej
Publicado: (2011)

Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis
por: Nikitopoulou, Ioanna, et al.
Publicado: (2012)

Autotaxin/lysophosphatidic acid signaling mediates obesity‐related cardiomyopathy in mice and human subjects
por: Weng, Jiakan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dquk62r8jr638g7ouiruao8gvi